REPORT ID 523

EMEA (Europe, Middle East and Africa) Transdermal Skin Patches Market Report 2017

Publish Date
04-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the EMEA Transdermal Skin Patches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Transdermal Skin Patches for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Transdermal Skin Patches market competition by top manufacturers/players, with Transdermal Skin Patches sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Johnson & Johnson
    Novartis AG
    Mylan N.V.
    Teva Pharmaceutical Industries
    Luye Pharma Group
    Hisamitsu Pharmaceutical
    Mundipharma International
    Purdue Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Drug in Adhesive
    Matrix
    Reservoir
    Vapor
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Transdermal Skin Patches Market Report 2017
1 Transdermal Skin Patches Overview
    1.1 Product Overview and Scope of Transdermal Skin Patches
    1.2 Classification of Transdermal Skin Patches
        1.2.1 EMEA Transdermal Skin Patches Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Transdermal Skin Patches Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Drug in Adhesive
        1.2.4 Matrix
        1.2.5 Reservoir
        1.2.6 Vapor
        1.2.7 Other
    1.3 EMEA Transdermal Skin Patches Market by Application/End Users
        1.3.1 EMEA Transdermal Skin Patches Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 EMEA Transdermal Skin Patches Market by Region
        1.4.1 EMEA Transdermal Skin Patches Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Transdermal Skin Patches (2012-2022)
        1.5.1 EMEA Transdermal Skin Patches Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Transdermal Skin Patches Revenue and Growth Rate (2012-2022)

2 EMEA Transdermal Skin Patches Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Transdermal Skin Patches Market Competition by Players/Manufacturers
        2.1.1 EMEA Transdermal Skin Patches Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Transdermal Skin Patches Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Transdermal Skin Patches Sale Price by Players (2012-2017)
    2.2 EMEA Transdermal Skin Patches (Volume and Value) by Type/Product Category
        2.2.1 EMEA Transdermal Skin Patches Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Transdermal Skin Patches Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Transdermal Skin Patches Sale Price by Type (2012-2017)
    2.3 EMEA Transdermal Skin Patches (Volume) by Application
    2.4 EMEA Transdermal Skin Patches (Volume and Value) by Region
        2.4.1 EMEA Transdermal Skin Patches Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Transdermal Skin Patches Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Transdermal Skin Patches Sales Price by Region (2012-2017)

3 Europe Transdermal Skin Patches (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Transdermal Skin Patches Sales and Value (2012-2017)
        3.1.1 Europe Transdermal Skin Patches Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Transdermal Skin Patches Revenue and Growth Rate (2012-2017)
    3.2 Europe Transdermal Skin Patches Sales and Market Share by Type
    3.3 Europe Transdermal Skin Patches Sales and Market Share by Application
    3.4 Europe Transdermal Skin Patches Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Transdermal Skin Patches Sales Volume by Countries (2012-2017)
        3.4.2 Europe Transdermal Skin Patches Revenue by Countries (2012-2017)
        3.4.3 Germany Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        3.4.4 France Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        3.4.5 UK Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        3.4.6 Russia Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        3.4.7 Italy Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Transdermal Skin Patches Sales and Growth Rate (2012-2017)

4 Middle East Transdermal Skin Patches (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Transdermal Skin Patches Sales and Value (2012-2017)
        4.1.1 Middle East Transdermal Skin Patches Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Transdermal Skin Patches Revenue and Growth Rate (2012-2017)
    4.2 Middle East Transdermal Skin Patches Sales and Market Share by Type
    4.3 Middle East Transdermal Skin Patches Sales and Market Share by Application
    4.4 Middle East Transdermal Skin Patches Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Transdermal Skin Patches Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Transdermal Skin Patches Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        4.4.4 Israel Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        4.4.5 UAE Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        4.4.6 Iran Transdermal Skin Patches Sales and Growth Rate (2012-2017)

5 Africa Transdermal Skin Patches (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Transdermal Skin Patches Sales and Value (2012-2017)
        5.1.1 Africa Transdermal Skin Patches Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Transdermal Skin Patches Revenue and Growth Rate (2012-2017)
    5.2 Africa Transdermal Skin Patches Sales and Market Share by Type
    5.3 Africa Transdermal Skin Patches Sales and Market Share by Application
    5.4 Africa Transdermal Skin Patches Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Transdermal Skin Patches Sales Volume by Countries (2012-2017)
        5.4.2 Africa Transdermal Skin Patches Revenue by Countries (2012-2017)
        5.4.3 South Africa Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Transdermal Skin Patches Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Transdermal Skin Patches Sales and Growth Rate (2012-2017)

6 EMEA Transdermal Skin Patches Manufacturers/Players Profiles and Sales Data
    6.1 Johnson & Johnson
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Transdermal Skin Patches Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis AG
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Transdermal Skin Patches Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis AG Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Mylan N.V.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Transdermal Skin Patches Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Teva Pharmaceutical Industries
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Transdermal Skin Patches Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Luye Pharma Group
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Transdermal Skin Patches Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Hisamitsu Pharmaceutical
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Transdermal Skin Patches Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Mundipharma International
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Transdermal Skin Patches Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Mundipharma International Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Purdue Pharma
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Transdermal Skin Patches Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Transdermal Skin Patches Manufacturing Cost Analysis
    7.1 Transdermal Skin Patches Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Transdermal Skin Patches

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Transdermal Skin Patches Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Transdermal Skin Patches Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Transdermal Skin Patches Market Forecast (2017-2022)
    11.1 EMEA Transdermal Skin Patches Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Transdermal Skin Patches Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Transdermal Skin Patches Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Transdermal Skin Patches Price and Trend Forecast (2017-2022)
    11.2 EMEA Transdermal Skin Patches Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Transdermal Skin Patches Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Transdermal Skin Patches Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Transdermal Skin Patches Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Transdermal Skin Patches Sales Forecast by Type (2017-2022)
    11.7 EMEA Transdermal Skin Patches Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer